Case Study: Reprieve Cardiovascular accelerates heart failure clinical development with Truveta

Reprieve Cardiovascular identifies 3x larger heart failure population with Truveta

Reprieve Cardiovascular, a company focused on heart failure treatment, faced the challenge of optimizing inpatient decongestion with outdated real-world data. They needed a contemporary, nationally representative dataset with rich clinical details to de-risk development and drive innovation, so they partnered with Truveta for its real-world data service.

Using Truveta's data, Reprieve was able to identify a patient population three times larger than the previous standard registry. This access to modern data validated the need for their new device and allowed them to optimize their clinical trial design by predicting enrollment and outcomes.

Reprieve Cardiovascular